Source file signed link, expires in 15 minutes
Extracted text 2
Page 1 OCR 0.943
PT TAISHO PHARMACEUTICAL INDONESIA TBK. Head Office: Millennium Centennial Center 8" fl, JL Jend. Sudirman Kav. 25 Jakarta 12920, INDONESIA - Phone: #62 21 3970 6720 Technical Operations: Jl. Raya Jakarta-Bogor Km. 38, Cilangkap, Tapos Depok 16458, INDONESIA - Phone: #62 21 875 2583 / 875 2584 Website: www.taisho.co.id SURAT PERNYATAAN DIREKSI TENTANG TANGGUNG JAWAB ATAS LAPORAN KEUANGAN TANGGAL 31 DESEMBER 2025 DAN UNTUK TAHUN YANG BERAKHIR PADA TANGGAL TERSEBUT PT TAISHO PHARMACEUTICAL INDONESIA Tbk DIRECTORS' STATEMENT ON THE RESPONSIBILITY FOR FINANCIAL STATEMENTS AS OF DECEMBER 31, 2025 AND FOR THE YEAR THEN ENDED PT TAISHO PHARMACEUTICAL INDONESIA Tbk Kami, yang bertanda tangan di bawah ini Taikan Abe Millenium Centennial Center 8" floor Jl. Jend. Sudirman Kav. 25 Jakarta 12950 1. Nama Alamat kantor Millenium Centennial Center 8th floor Jl. Jend. Sudirman Kav. 25 Jakarta 12950 Alamat domisili atau sesuai KTP Nomor telepon (021) 3970-6720 Jabatan Direktur / Director 2. Nama M. Edwin Isfandiari Millenium Centennial Center 8" floor Jl. Jend. Sudirman Kav. 25 Jakarta 12950 Alamat kantor Millenium Centennial Center 8" floor Jl. Jend. Sudirman Kav. 25 Jakarta 12950 (021) 3970-6720 Direktur / Director Alamat domisili atau sesuai KTP Nomor telepon Jabatan We, the undersigned below: Name Office address Domicile address or address according to ID Telephone number Title Name Office address Domicile address or address according to ID Telephone number Title menyatakan bahwa: declare that: accordance with 1. Kami bertanggung jawab atas penyusunan dan 1. We are responsible for the preparation and penyajian laporan keuangan PT Taisho presentation of the financial statements of PT Taisho Pharmaceutical Indonesia Tbk (“Perusahaan"'): Pharmaceutical Indonesia Tbk (the “Company”): 2. Laporan keuangan Perusahaan telah disusun dan 2. The financial statements of the Company have been disajikan sesuai dengan Standar Akuntansi Keuangan prepared and presented in di Indonesia, Indonesian Financial Accounting Standards, 3. a. Semua informasi dalam laporan keuangan 3. a. All information in the financial statements of the Perusahaan telah dimuat secara lengkap dan Company have been disclosed in a complete and benar, truthful manner, b. Laporan keuangan Perusahaan tidak b. The financial statements of the Company do not mengandung informasi atau fakta material yang contain any incorrect material information or fact, tidak benar, dan tidak menghilangkan informasi nor do they omit any material information or fact: atau fakta material, 4. Kami bertanggung jawab atas sistem pengendalian 4. We are responsible for the intemal control system of internal dalam Perusahaan. the Company.
Page 2 OCR 0.883
PT TAISHO PHARMACEUTICAL INDONESIA TBK. Head Office: Millennium Centennial Center 8" fl, JL Jend. Sudirman Kav. 25 Jakarta 12920, INDONESIA - Phone: #62 21 3970 6720 Technical Operations: Jl. Raya Jakarta-Bogor Km. 38, Cilangkap, Tapos Depok 16458, INDONESIA - Phone: #62 21 875 2583 / 875 2584 Website: www.taisho.co.id Demikian pernyataan ini dibuat dengan sebenarnya. This statement is made truthfully. Jakarta, 6 Maret 2026 / March 6, 2026 PT Taisho Pharmaceutical Indonesia Tbk "" METERAI TEMPEL 'ANX320930332 Pa Taikan Abe M. Edwin Isfandiari Direktur / Director Direktur / Director
Names mentioned 3 people and organisations named in the text · linked when the evidence is strong
unresolved
org
TAISHO PHARMACEUTICAL INDONESIA TBK.
p.1 ×12
unresolved
org
PT Taisho
p.1
unresolved
org
Pharmaceutical Indonesia Tbk
p.1
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.